Global Fluticasone propionate Market Overview:
Fluticasone propionate is a medication belongs to a corticosteroid class of drugs. It is used in the treatment of allergic rhinitis, asthma, various skin disorders, nasal polyps, ulcerative colitis, and Crohn's disease. Fluticasone propionate market has high growth prospects owing to the increasing prevalence of chronic obstructive pulmonary disease and asthma. In addition, rising demand from the developing economies expected to drive the market demand. Some of the key players profiled in the study are GSK (United Kingdom), Teva Pharmaceutical Industries (Israel), West-Ward Pharmaceuticals (United States), Apotex Corp. (United States), Akorn (United States), Wockhardt (India) and OptiNose US, Inc. (United States).
On the basis of geography, the market of Fluticasone propionate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. Direct will boost the Fluticasone propionate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Number of Patients with Asthmatic Condition
- Growing Demand for Nasal Sprays
- Increasing Applications in the Treatment of Allergic and Non-Allergic Nasal Indications
- Stringent Government Regulations Regarding Fluticasone Propionate
- Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD)
- Increasing Demand from the Developing Economies
- Side Effects Such As Sinusitis, Upper Respiratory Tract Infections, and Others
“According to the National Center for Biotechnology Information, Fluticasone propionate (FP) is a new topical corticosteroid spray used for the treatment of allergic rhinitis and asthma. FP has been shown to be effective for the treatment of adult and pediatric asthma, even at rather low doses (25 microg twice daily [b.i.d.]); many studies in asthma have shown clinical efficacy of fluticasone at half the dose of the comparison steroid (such as beclomethasone dipropionate [BDP] or budesonide [BUD]). However, exact dose comparisons cannot be made because dose-ranging comparison studies have not been done. Studies in allergic rhinitis in children and adults have shown good efficacy in FP-treated patients at a dose of 200 microg once daily (o.d.), intranasally.”
Target Audience:Fluticasone Propionate Manufacturers, Fluticasone Propionate Distributors, Government Agencies, Commercial Research & Development Institutions, Government Organizations, Research Organizations, and Consulting Firms, Trade Associations and Industry Bodies and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Fluticasone propionate market on the basis of product [60 Metered Sprays, 120 Metered Sprays and 150 Metered Sprays] , application [Adult and Kids], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Fluticasone propionate market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Fluticasone propionate industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Vendors which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Fluticasone propionate market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.